Melissa Plets
Impact in
-
- Renal cell carcinoma treatment
- Prostate Cancer Treatment and Research
- Oncology top 10%
- Cancer Immunotherapy and Biomarkers
Papers in
- Surgery 26
- Bladder and Urothelial Cancer Treatments 25
- Urinary and Genital Oncology Studies 6
-
- Renal cell carcinoma treatment 12
- Prostate Cancer Treatment and Research 10
- Co-authors
- Ian M. Thompson (46 shared papers)Catherine M. Tangen (38 shared papers)Seth P. Lerner (28 shared papers)Nicholas J. Vogelzang (15 shared papers)Primo N. Lara (19 shared papers)Ajjai Alva (11 shared papers)David J. McConkey (20 shared papers)Elad Sharon (10 shared papers)
- Journals
- Journal of Clinical Oncology (26 papers)Clinical Cancer Research (3 papers)JAMA Network Open (3 papers)European Urology (3 papers)European Urology Oncology (2 papers)
- Partner nations
- United StatesCanadaSouth Africa
In The Last Decade
Melissa Plets
55 papers receiving 1.2k citations
Melissa Plets's Hit Papers
Peers
Comparison fields: 5 of 61
- Pulmonary and Respiratory Medicine 462
- Oncology 344
- Cancer Research 186
- Urology 76
- Surgery 533
Countries citing papers authored by Melissa Plets
This map shows the geographic impact of Melissa Plets's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Melissa Plets with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Melissa Plets more than expected).
Fields of papers citing papers by Melissa Plets
This network shows the impact of papers produced by Melissa Plets. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Melissa Plets. The network helps show where Melissa Plets may publish in the future.
Co-authors
The 25 scholars most cited alongside Melissa Plets, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 58 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | A comparison of sunitinib with cabozantinib, crizotinib, and savolitinib for treatment of advanced papillary renal cell carcinoma: a randomised, open-label, phase 2 trial Hit paper breakdown → | 2021 | 180 |
| 2 | 2018 | 154 | |
| 3 | 2021 | 112 | |
| 4 | 2021 | 80 | |
| 5 | 2021 | 59 | |
| 6 | 2023 | 54 | |
| 7 | 2020 | 45 | |
| 8 | 2017 | 40 | |
| 9 | 2022 | 31 | |
| 10 | 2017 | 30 | |
| 11 | 2023 | 28 | |
| 12 | 2022 | 26 | |
| 13 | 2024 | 25 | |
| 14 | 2023 | 23 | |
| 15 | 2021 | 22 | |
| 16 | 2023 | 21 | |
| 17 | 2021 | 21 | |
| 18 | 2020 | 21 | |
| 19 | 2019 | 21 | |
| 20 | 2024 | 19 |
About Melissa Plets
Melissa Plets is a scholar working on Surgery, Pulmonary and Respiratory Medicine, Oncology, Molecular Biology and Cancer Research, having authored 58 papers that have together received 1.2k indexed citations. Recurring topics across this work include Bladder and Urothelial Cancer Treatments (25 papers), Renal cell carcinoma treatment (12 papers), Prostate Cancer Treatment and Research (10 papers), Cancer Immunotherapy and Biomarkers (8 papers), Urinary and Genital Oncology Studies (6 papers), Cancer Genomics and Diagnostics (5 papers), Cancer Research and Treatments (5 papers) and Epigenetics and DNA Methylation (4 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (462 citations), Oncology (344 citations), Cancer Research (186 citations), Urology (76 citations) and Surgery (533 citations). Melissa Plets has collaborated with scholars based in United States, Canada and South Africa. Frequent co-authors include Ian M. Thompson, Catherine M. Tangen, Seth P. Lerner, Nicholas J. Vogelzang, Primo N. Lara, Ajjai Alva, David J. McConkey, Elad Sharon, Sandip Pravin Patel and Sumanta K. Pal. Their work appears in journals such as Journal of Clinical Oncology, Clinical Cancer Research, JAMA Network Open, European Urology and European Urology Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.